CGTN published this video item, entitled “Nurse first in Brazil to get Chinese COVID-19 vaccine” – below is their description.
On January 17, nurse Monica Calazans became the first person in Brazil to receive a dose of the COVID-19 vaccine developed by Chinese biotech firm Sinovac. 54-year-old Calazans has diabetes and is considered to be at high-risk from the coronavirus. Earlier that day, the Brazilian health regulator approved the urgent use of coronavirus vaccines made by Sinovac and AstraZeneca.
AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.
Brazil is the largest country in both South America and Latin America.
Its capital is Brasília, and its most populous city is São Paulo. The federation is composed of the union of the 26 states and the Federal District. It is the largest country to have Portuguese as an official language and the only one in the Americas, as well as the most populous Roman Catholic-majority country.
Its Amazon basin includes a vast tropical forest, home to diverse wildlife, a variety of ecological systems, and extensive natural resources spanning numerous protected habitats. Brazil is classified as an upper-middle income economy by the World Bank and a newly industrialized country.
A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.